{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:25:25Z","timestamp":1791739525831,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203789"],"award-info":[{"award-number":["82203789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102683"],"award-info":[{"award-number":["82102683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10549-023-07153-1","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T09:01:39Z","timestamp":1698483699000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients"],"prefix":"10.1007","volume":"203","author":[{"given":"Yuan-Yuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-5819","authenticated-orcid":false,"given":"Shuang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"key":"7153_CR1","unstructured":"Eble JN, Tavassoli FA, Devilee P (2003) Pathology and genetics of tumours of the breast and female genital organs. Iarc"},{"key":"7153_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.1966.03100050096033","volume":"195","author":"RW McDivitt","year":"1966","unstructured":"McDivitt RW, Stewart FW (1966) Breast carcinoma in children. JAMA 195:388\u2013390","journal-title":"JAMA"},{"key":"7153_CR3","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/1097-0142(19800501)45:9<2404::aid-cncr2820450928>3.0.co;2-8","volume":"45","author":"FA Tavassoli","year":"1980","unstructured":"Tavassoli FA, Norris HJ (1980) Secretory carcinoma of the breast. Cancer 45:2404\u20132413. https:\/\/doi.org\/10.1002\/1097-0142(19800501)45:9%3c2404::aid-cncr2820450928%3e3.0.co;2-8","journal-title":"Cancer"},{"key":"7153_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/bf02574482","volume":"9","author":"E de Bree","year":"2002","unstructured":"de Bree E et al (2002) Secretory carcinoma of the male breast. Ann Surg Oncol 9:663\u2013667. https:\/\/doi.org\/10.1007\/bf02574482","journal-title":"Ann Surg Oncol"},{"key":"7153_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5152\/bs.2016.3249","volume":"12","author":"F Aktepe","year":"2016","unstructured":"Aktepe F, Sarsenov D, \u00d6zmen V (2016) Secretory carcinoma of the breast. J Breast Health 12:174\u2013176. https:\/\/doi.org\/10.5152\/bs.2016.3249","journal-title":"J Breast Health"},{"key":"7153_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jso.24241","volume":"113","author":"JD Jacob","year":"2016","unstructured":"Jacob JD et al (2016) Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol 113:721\u2013725. https:\/\/doi.org\/10.1002\/jso.24241","journal-title":"J Surg Oncol"},{"key":"7153_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s1535-6108(02)00180-0","volume":"2","author":"C Tognon","year":"2002","unstructured":"Tognon C et al (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367\u2013376. https:\/\/doi.org\/10.1016\/s1535-6108(02)00180-0","journal-title":"Cancer Cell"},{"key":"7153_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/modpathol.2008.184","volume":"22","author":"M La\u00e9","year":"2009","unstructured":"La\u00e9 M et al (2009) Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol 22:291\u2013298. https:\/\/doi.org\/10.1038\/modpathol.2008.184","journal-title":"Mod Pathol"},{"key":"7153_CR9","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/pas.0000000000000487","volume":"39","author":"M Del Castillo","year":"2015","unstructured":"Del Castillo M et al (2015) Secretory breast carcinoma: a histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol 39:1458\u20131467. https:\/\/doi.org\/10.1097\/pas.0000000000000487","journal-title":"Am J Surg Pathol"},{"key":"7153_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/pas.0000000000000734","volume":"41","author":"JA Bishop","year":"2017","unstructured":"Bishop JA et al (2017) Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands. Am J Surg Pathol 41:62\u201366. https:\/\/doi.org\/10.1097\/pas.0000000000000734","journal-title":"Am J Surg Pathol"},{"key":"7153_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000086782","volume":"68","author":"M Ozguroglu","year":"2005","unstructured":"Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V (2005) Secretory carcinoma of the breast: case report and review of the literature. Oncology 68:263\u2013268. https:\/\/doi.org\/10.1159\/000086782","journal-title":"Oncology"},{"key":"7153_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.breast.2012.02.013","volume":"21","author":"DP Horowitz","year":"2012","unstructured":"Horowitz DP, Sharma CS, Connolly E, Gidea-Addeo D, Deutsch I (2012) Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast 21:350\u2013353. https:\/\/doi.org\/10.1016\/j.breast.2012.02.013","journal-title":"Breast"},{"key":"7153_CR13","first-page":"457","volume":"15","author":"M Tokunaga","year":"1985","unstructured":"Tokunaga M et al (1985) Juvenile secretory carcinoma and juvenile papillomatosis. Jpn J Clin Oncol 15:457\u2013465","journal-title":"Jpn J Clin Oncol"},{"key":"7153_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/dc.2840030312","volume":"3","author":"GK Nguyen","year":"1987","unstructured":"Nguyen GK, Neifer R (1987) Aspiration biopsy cytology of secretory carcinoma of the breast. Diagn Cytopathol 3:234\u2013237. https:\/\/doi.org\/10.1002\/dc.2840030312","journal-title":"Diagn Cytopathol"},{"key":"7153_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2559.1989.tb02111.x","volume":"14","author":"T Krausz","year":"1989","unstructured":"Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG (1989) Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology 14:25\u201336. https:\/\/doi.org\/10.1111\/j.1365-2559.1989.tb02111.x","journal-title":"Histopathology"},{"key":"7153_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-2008-1035759","volume":"49","author":"M Krohn","year":"1989","unstructured":"Krohn M, Trams G, Brandt G (1989) Secretory breast cancer. A special morphologic entity, especially in children and young females. Geburtshilfe Frauenheilkd 49:299\u2013301. https:\/\/doi.org\/10.1055\/s-2008-1035759","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"7153_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1023\/a:1008387800525","volume":"11","author":"H Herz","year":"2000","unstructured":"Herz H, Cooke B, Goldstein D (2000) Metastatic secretory breast cancer: non-responsiveness to chemotherapy: case report and review of the literature. Ann Oncol 11:1343\u20131347. https:\/\/doi.org\/10.1023\/a:1008387800525","journal-title":"Ann Oncol"},{"issue":"432\u2013435","key":"7153_CR18","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/s0242-6498(04)93999-5","volume":"24","author":"G Woto-Gaye","year":"2004","unstructured":"Woto-Gaye G, Kasse AA, Dieye Y, Toure P, Demba Ndiaye P (2004) Secretory breast carcinoma in a man: a case report with rapid evolution unfavorable. Ann Pathol 24(432\u2013435):2004. https:\/\/doi.org\/10.1016\/s0242-6498(04)93999-5","journal-title":"Ann Pathol"},{"key":"7153_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7819-3-35","volume":"3","author":"C Arce","year":"2005","unstructured":"Arce C et al (2005) Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol 3:35. https:\/\/doi.org\/10.1186\/1477-7819-3-35","journal-title":"World J Surg Oncol"},{"key":"7153_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5858\/2006-130-e50-ALFBM","volume":"130","author":"P Anderson","year":"2006","unstructured":"Anderson P, Albarracin CT, Resetkova E (2006) A large, fungating breast mass: secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med 130:50\u201352. https:\/\/doi.org\/10.5858\/2006-130-e50-ALFBM","journal-title":"Arch Pathol Lab Med"},{"key":"7153_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/tbj.12041","volume":"18","author":"M Wong","year":"2012","unstructured":"Wong M et al (2012) ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J 18:604\u2013606. https:\/\/doi.org\/10.1111\/tbj.12041","journal-title":"Breast J"},{"key":"7153_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3760\/cma.j.issn.0529-5807.2017.02.017","volume":"46","author":"J Lian","year":"2017","unstructured":"Lian J et al (2017) Secretory breast carcinoma with liver metastatic: report of a case. Zhonghua Bing Li Xue Za Zhi 46:124\u2013125. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5807.2017.02.017","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"7153_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/his.13879","volume":"75","author":"RS Hoda","year":"2019","unstructured":"Hoda RS et al (2019) Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential. Histopathology 75:213\u2013224. https:\/\/doi.org\/10.1111\/his.13879","journal-title":"Histopathology"},{"key":"7153_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13000-021-01115-1","volume":"16","author":"H Tang","year":"2021","unstructured":"Tang H et al (2021) Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review. Diagn Pathol 16:56. https:\/\/doi.org\/10.1186\/s13000-021-01115-1","journal-title":"Diagn Pathol"},{"key":"7153_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13000-021-01156-6","volume":"16","author":"J Lian","year":"2021","unstructured":"Lian J et al (2021) Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review. Diagn Pathol 16:89. https:\/\/doi.org\/10.1186\/s13000-021-01156-6","journal-title":"Diagn Pathol"},{"key":"7153_CR26","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/jco.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME et al (2010) American society of clinical oncology\/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784\u20132795. https:\/\/doi.org\/10.1200\/jco.2009.25.6529","journal-title":"J Clin Oncol"},{"key":"7153_CR27","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/jco.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 36:2105\u20132122. https:\/\/doi.org\/10.1200\/jco.2018.77.8738","journal-title":"J Clin Oncol"},{"key":"7153_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/annonc\/mdz384","volume":"30","author":"JP Solomon","year":"2019","unstructured":"Solomon JP, Benayed R, Hechtman JF, Ladanyi M (2019) Identifying patients with NTRK fusion cancer. Ann Oncol 30:816\u2013822. https:\/\/doi.org\/10.1093\/annonc\/mdz384","journal-title":"Ann Oncol"},{"key":"7153_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAS.0b013e318231542a","volume":"36","author":"A Connor","year":"2012","unstructured":"Connor A, Perez-Ordo\u00f1ez B, Shago M, Sk\u00e1lov\u00e1 A, Weinreb I (2012) Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 36:27\u201334. https:\/\/doi.org\/10.1097\/PAS.0b013e318231542a","journal-title":"Am J Surg Pathol"},{"key":"7153_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1162\/003465302317331982","volume":"84","author":"RH Dehejia","year":"2002","unstructured":"Dehejia RH, Wahba S (2002) Propensity Score-Matching Methods for Nonexperimental Causal Studies. Rev Econ Stat 84:151\u2013161. https:\/\/doi.org\/10.1162\/003465302317331982","journal-title":"Rev Econ Stat"},{"key":"7153_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pst.2051","volume":"20","author":"J Wang","year":"2021","unstructured":"Wang J (2021) To use or not to use propensity score matching? Pharm Stat 20:15\u201324. https:\/\/doi.org\/10.1002\/pst.2051","journal-title":"Pharm Stat"},{"key":"7153_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/bsd.0000000000001055","volume":"34","author":"JH Badhiwala","year":"2021","unstructured":"Badhiwala JH, Karmur BS, Wilson JR (2021) Propensity score matching: a powerful tool for analyzing observational nonrandomized data. Clin Spine Surg 34:22\u201324. https:\/\/doi.org\/10.1097\/bsd.0000000000001055","journal-title":"Clin Spine Surg"},{"key":"7153_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150\u2013161","journal-title":"Pharm Stat"},{"key":"7153_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/s1470-2045(16)30017-1","volume":"17","author":"PA Ascierto","year":"2016","unstructured":"Ascierto PA, Long GV (2016) Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials. Lancet Oncol 17:1037\u20131039. https:\/\/doi.org\/10.1016\/s1470-2045(16)30017-1","journal-title":"Lancet Oncol"},{"key":"7153_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B De Bruyne","year":"2012","unstructured":"De Bruyne B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991\u20131001. https:\/\/doi.org\/10.1056\/NEJMoa1205361","journal-title":"N Engl J Med"},{"key":"7153_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7150\/jca.47125","volume":"12","author":"J Fu","year":"2021","unstructured":"Fu J et al (2021) Distinct impacts of pre-operative antiviral treatment on post-operative outcomes of HBV-related hepatocellular carcinoma: a landmark analysis. J Cancer 12:170\u2013180. https:\/\/doi.org\/10.7150\/jca.47125","journal-title":"J Cancer"},{"key":"7153_CR37","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hed.25536","volume":"41","author":"G Ayre","year":"2019","unstructured":"Ayre G et al (2019) Secretory carcinoma of the major salivary gland: Provincial population-based analysis of clinical behavior and outcomes. Head Neck 41:1227\u20131236. https:\/\/doi.org\/10.1002\/hed.25536","journal-title":"Head Neck"},{"key":"7153_CR38","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.oooo.2020.04.007","volume":"132","author":"LDB Alves","year":"2021","unstructured":"Alves LDB et al (2021) A systematic review of secretory carcinoma of the salivary gland: where are we? Oral Surg Oral Med Oral Pathol Oral Radiol 132:e143\u2013e152. https:\/\/doi.org\/10.1016\/j.oooo.2020.04.007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"7153_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41379-019-0427-1","volume":"33","author":"K Na","year":"2020","unstructured":"Na K, Hernandez-Prera JC, Lim JY, Woo HY, Yoon SO (2020) Characterization of novel genetic alterations in salivary gland secretory carcinoma. Mod Pathol 33:541\u2013550. https:\/\/doi.org\/10.1038\/s41379-019-0427-1","journal-title":"Mod Pathol"},{"key":"7153_CR40","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu YH et al (2020) Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Mod Pathol 33:2186\u20132197. https:\/\/doi.org\/10.1038\/s41379-020-0574-4","journal-title":"Mod Pathol"},{"key":"7153_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105092","volume":"115","author":"NS Huang","year":"2021","unstructured":"Huang NS et al (2021) Mammary analog secretory carcinoma of the thyroid gland: a rare cancer harboring TRK fusion. Oral Oncol 115:105092. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.105092","journal-title":"Oral Oncol"},{"key":"7153_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/modpathol.2011.190","volume":"25","author":"D Li","year":"2012","unstructured":"Li D et al (2012) Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol 25:567\u2013575. https:\/\/doi.org\/10.1038\/modpathol.2011.190","journal-title":"Mod Pathol"},{"key":"7153_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/mpo.2950200415","volume":"20","author":"F Serour","year":"1992","unstructured":"Serour F, Gilad A, Kopolovic J, Krispin M (1992) Secretory breast cancer in childhood and adolescence: report of a case and review of the literature. Med Pediatr Oncol 20:341\u2013344. https:\/\/doi.org\/10.1002\/mpo.2950200415","journal-title":"Med Pediatr Oncol"},{"key":"7153_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-018-4772-4","volume":"170","author":"M Ghilli","year":"2018","unstructured":"Ghilli M et al (2018) Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature. Breast Cancer Res Treat 170:445\u2013454. https:\/\/doi.org\/10.1007\/s10549-018-4772-4","journal-title":"Breast Cancer Res Treat"},{"key":"7153_CR45","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10549-011-1869-4","volume":"133","author":"C Cabello","year":"2012","unstructured":"Cabello C et al (2012) Case report and review of the literature: secretory breast cancer in a 13-year-old boy\u201310 years of follow up. Breast Cancer Res Treat 133:813\u2013820. https:\/\/doi.org\/10.1007\/s10549-011-1869-4","journal-title":"Breast Cancer Res Treat"},{"key":"7153_CR46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jjco\/hyr187","volume":"42","author":"K Yorozuya","year":"2012","unstructured":"Yorozuya K et al (2012) A case of estrogen receptor positive secretory carcinoma in a 9-Year-old girl with ETV6-NTRK3 fusion gene. Jpn J Clin Oncol 42:208\u2013211. https:\/\/doi.org\/10.1093\/jjco\/hyr187","journal-title":"Jpn J Clin Oncol"},{"key":"7153_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2018.0035","volume":"16","author":"L Li","year":"2019","unstructured":"Li L et al (2019) Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med 16:139\u2013146. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2018.0035","journal-title":"Cancer Biol Med"},{"key":"7153_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.breast.2004.02.011","volume":"13","author":"J Sz\u00e1nt\u00f3","year":"2004","unstructured":"Sz\u00e1nt\u00f3 J et al (2004) Secretory breast cancer in a 75-year old boy. Breast 13:439\u2013442. https:\/\/doi.org\/10.1016\/j.breast.2004.02.011","journal-title":"Breast"},{"key":"7153_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00383-015-3721-0","volume":"31","author":"T Soyer","year":"2015","unstructured":"Soyer T et al (2015) Secretory breast carcinoma in a 6-year-old girl: mastectomy with sentinel lymph node dissection. Pediatr Surg Int 31:677\u2013681. https:\/\/doi.org\/10.1007\/s00383-015-3721-0","journal-title":"Pediatr Surg Int"},{"key":"7153_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/00313027709094454","volume":"9","author":"JJ Sullivan","year":"1977","unstructured":"Sullivan JJ, Magee HR, Donald KJ (1977) Secretory (juvenile) carcinoma of the breast. Pathology 9:341\u2013346. https:\/\/doi.org\/10.3109\/00313027709094454","journal-title":"Pathology"},{"key":"7153_CR51","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1200\/jco.2013.49.5283","volume":"31","author":"A Giobbie-Hurder","year":"2013","unstructured":"Giobbie-Hurder A, Gelber RD, Regan MM (2013) Challenges of guarantee-time bias. J Clin Oncol 31:2963\u20132969. https:\/\/doi.org\/10.1200\/jco.2013.49.5283","journal-title":"J Clin Oncol"},{"key":"7153_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/circoutcomes.110.957951","volume":"4","author":"U Dafni","year":"2011","unstructured":"Dafni U (2011) Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes 4:363\u2013371. https:\/\/doi.org\/10.1161\/circoutcomes.110.957951","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"7153_CR53","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/jco.1983.1.11.710","volume":"1","author":"JR Anderson","year":"1983","unstructured":"Anderson JR, Cain KC, Gelber RD (1983) Analysis of survival by tumor response. J Clin Oncol 1:710\u2013719. https:\/\/doi.org\/10.1200\/jco.1983.1.11.710","journal-title":"J Clin Oncol"},{"key":"7153_CR54","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1200\/jco.2008.16.1000","volume":"26","author":"JR Anderson","year":"2008","unstructured":"Anderson JR, Cain KC, Gelber RD (2008) Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. J Clin Oncol 26:3913\u20133915. https:\/\/doi.org\/10.1200\/jco.2008.16.1000","journal-title":"J Clin Oncol"},{"key":"7153_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.anndiagpath.2012.06.001","volume":"17","author":"NU Din","year":"2013","unstructured":"Din NU, Idrees R, Fatima S, Kayani N (2013) Secretory carcinoma of breast: clinicopathologic study of 8 cases. Ann Diagn Pathol 17:54\u201357. https:\/\/doi.org\/10.1016\/j.anndiagpath.2012.06.001","journal-title":"Ann Diagn Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07153-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:20:26Z","timestamp":1706008826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["7153"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07153-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,28]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This is a retrospective cohort study conducted under the approval of Institutional Review Board of Shanghai Cancer Center, Fudan University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}